Morphic Therapeutic Competitors and Similar CompaniesClear all
Morphic Therapeutic's competitors and similar companies include Alzheon and Vedanta Biosciences.
 Alzheon Alzheon is a company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders. |  Vedanta Biosciences Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. | ||
Founding Date | Founding Date 2015 | Founding Date 2013 | Founding Date 2010 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Waltham, US HQ | Locations Framingham, US HQ | Locations Cambridge, US HQ |
Employees | Employees 76 | Employees 3310% increase | Employees 1381% increase |
Financial | |||
Net income | Net income ($152.1m) (FY, 2023) | Net income ($5.5m) (FY, 2017) | Net income N/A |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 15.8m (almost 9 years ago) | Latest funding round $ 68m (almost 5 years ago) |
Total funding raised | Total funding raised $ 131.5m | Total funding raised $ 37.1m | Total funding raised $ 185.5m |
For sources of this data, please see the company profile
View Company Profiles
Alzheon
HQ
Framingham, US
Employees
33↑ 10% increase
Alzheon is a company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.
View companyVedanta Biosciences
HQ
Cambridge, US
Employees
138↑ 1% increase
Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
View company